IRIS
SPECCHIA, Giorgina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.753
AS - Asia 9.258
EU - Europa 8.760
SA - Sud America 2.562
AF - Africa 520
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 45.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.409
SG - Singapore 3.788
CN - Cina 2.185
DE - Germania 2.089
BR - Brasile 2.024
RU - Federazione Russa 1.874
HK - Hong Kong 1.177
SE - Svezia 1.098
IT - Italia 964
GB - Regno Unito 628
VN - Vietnam 626
FR - Francia 575
FI - Finlandia 546
UA - Ucraina 439
IN - India 320
AR - Argentina 192
BD - Bangladesh 182
CI - Costa d'Avorio 170
CA - Canada 159
IQ - Iraq 122
ID - Indonesia 120
ZA - Sudafrica 113
MX - Messico 106
TR - Turchia 101
PK - Pakistan 86
PL - Polonia 84
CO - Colombia 77
BE - Belgio 73
IE - Irlanda 73
EC - Ecuador 67
JP - Giappone 66
UZ - Uzbekistan 62
VE - Venezuela 62
SA - Arabia Saudita 61
PH - Filippine 56
MA - Marocco 55
NL - Olanda 51
ES - Italia 48
CL - Cile 40
AT - Austria 36
PY - Paraguay 36
TN - Tunisia 35
MY - Malesia 32
CZ - Repubblica Ceca 31
JO - Giordania 30
KE - Kenya 28
NP - Nepal 28
LT - Lituania 27
KR - Corea 25
EG - Egitto 24
PE - Perù 24
IL - Israele 21
UY - Uruguay 21
ET - Etiopia 20
KZ - Kazakistan 20
OM - Oman 20
DZ - Algeria 19
JM - Giamaica 18
RO - Romania 18
AE - Emirati Arabi Uniti 17
IR - Iran 16
AZ - Azerbaigian 15
CH - Svizzera 13
RS - Serbia 13
AU - Australia 12
BO - Bolivia 11
TH - Thailandia 11
BY - Bielorussia 10
PA - Panama 10
SN - Senegal 10
CR - Costa Rica 9
PS - Palestinian Territory 9
PT - Portogallo 9
DO - Repubblica Dominicana 8
HN - Honduras 8
LB - Libano 8
HU - Ungheria 7
TW - Taiwan 7
AO - Angola 6
BG - Bulgaria 6
EU - Europa 6
GE - Georgia 6
KG - Kirghizistan 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
EE - Estonia 5
GR - Grecia 5
HR - Croazia 5
KW - Kuwait 5
MD - Moldavia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BN - Brunei Darussalam 4
GT - Guatemala 4
KH - Cambogia 4
MT - Malta 4
NG - Nigeria 4
QA - Qatar 4
Totale 45.792
Salva come PNG Salva come JPEG
Città #
Fairfield 3.138
Ashburn 2.509
Woodbridge 2.046
Singapore 2.032
Houston 1.574
Chandler 1.570
Seattle 1.333
Hong Kong 1.171
Cambridge 1.130
San Jose 1.030
Wilmington 1.030
Ann Arbor 987
Jacksonville 984
Nyköping 853
Beijing 621
New York 508
Lawrence 375
Roxbury 375
Los Angeles 367
Lauterbourg 365
Nanjing 291
Dallas 263
Bari 260
Des Moines 255
Boardman 218
Ho Chi Minh City 208
Helsinki 207
Munich 171
Abidjan 169
São Paulo 167
Princeton 164
San Diego 155
Brooklyn 149
Inglewood 135
Council Bluffs 124
Hanoi 121
Santa Clara 118
Buffalo 103
Moscow 99
Shenyang 92
Hebei 89
Nanchang 89
Falkenstein 87
London 87
Dearborn 80
Brussels 71
Frankfurt am Main 70
Dublin 68
Jakarta 68
Jiaxing 68
Chicago 63
Johannesburg 63
Rio de Janeiro 62
Tianjin 62
Warsaw 62
Redwood City 61
Changsha 60
Pune 60
Tashkent 57
Baghdad 55
Denver 55
Chennai 51
Paris 51
Tokyo 51
Atlanta 48
Belo Horizonte 48
Montreal 48
Rome 44
Turku 43
Nuremberg 42
The Dalles 42
Guangzhou 39
Orem 39
Marseille 38
Brasília 37
Dong Ket 37
Shanghai 35
Columbus 34
Curitiba 34
Toronto 34
San Francisco 33
Dhaka 32
Mexico City 31
Milan 31
Phoenix 30
Lahore 29
Boston 28
Porto Alegre 28
Stockholm 27
Guayaquil 26
Haiphong 26
Jinan 26
Ankara 25
Jeddah 25
Medellín 25
Quito 25
Buenos Aires 24
Nairobi 24
Poplar 24
Amsterdam 23
Totale 30.241
Salva come PNG Salva come JPEG
Nome #
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia 735
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 251
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 244
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 227
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 218
Monosomal karyotype in myeloid neoplasias: a literature review 217
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 213
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 207
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 207
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 206
Isolation and characterization of neural stem cells from dystrophic mdx mouse 200
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 200
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 196
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 195
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 193
A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow 193
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 193
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 192
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 188
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 188
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 187
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 185
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 182
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 182
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 182
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 181
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 180
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 178
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 177
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 176
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 174
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 170
Non-treatment-related chronic myeloid leukemia as a second malignancy 168
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 166
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 166
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 165
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 165
Decreased TET2 gene expression during chronic myeloid leukemia progression 164
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 164
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 164
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 162
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 161
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 161
Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia 160
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 160
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 159
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 159
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 158
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 158
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 158
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 156
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 156
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 155
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 153
Cardiovascular events and intensity of treatment in polycythemia vera. 153
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 152
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 151
CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) 151
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 150
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 150
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 150
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 149
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 148
Typhlitis complicating induction therapy in adult acute myeloid leukemia 147
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 146
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 146
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 146
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 146
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 145
Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature 144
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 143
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 143
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 142
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 141
ANALYSIS OF PROGNOSTIC FACTORS AND TIME TO FIRST TREATMENT IN YOUNG PATIENTS (<55 YEARS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTER EXPERIENCE 141
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 140
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 139
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 139
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 137
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 136
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 136
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 135
A case of light chain (AL) amyloidosis associated with IgD Multiple Myeloma (MM): clinical features, laboratory findings and outcome 135
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 135
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 134
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 134
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 134
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 132
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 132
Autoimmune Myelofibrosis: report of three cases and review of the literature 131
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 131
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 131
Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice 131
DARA-VD VERSUS DARA-RD AS SALVAGE THERAPY FOR PATIENTS WITH MYELOMA. INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY RETE EMATOLOGICA PUGLIESE 131
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 130
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 130
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 130
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. 128
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 128
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 128
Totale 16.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.010 0 0 0 0 0 0 0 0 0 504 268 238
2021/20222.686 205 263 26 89 126 258 129 123 207 218 449 593
2022/20234.152 611 496 252 349 480 587 42 462 684 31 76 82
2023/20241.760 160 277 73 88 181 596 32 49 9 62 28 205
2024/20256.614 192 123 538 273 178 576 616 597 299 392 940 1.890
2025/202613.280 1.987 660 987 1.798 1.669 822 1.528 419 2.157 1.253 0 0
Totale 46.772